Regulatory and nonclinical considerations for translation of gene therapy medicinal products to first-in-human clinical trials

Research output: Indexed journal article › Meeting Abstract

Translated title of the contribution	Regulatory and nonclinical considerations for translation of gene therapy medicinal products to first-in-human clinical trials
Original language	English
Pages (from-to)	A209-A210
Number of pages	2
Journal	Human Gene Therapy
Volume	30
Issue number	11
Publication status	Published - 1 Nov 2019
Event	ESGCT 27th Annual Congress - Duration: 1 Jan 2019 → …

Cite this

@article{0b2278a121124f57b190383576cb74da,

title = "Regulatory and nonclinical considerations for translation of gene therapy medicinal products to first-in-human clinical trials",

author = "\{Montan{\'e} Mogas\}, Joel",

note = "J Montane,M Rayo, O Penon, N Coderch, C J Mann; ESGCT 27th Annual Congress ; Conference date: 01-01-2019",

year = "2019",

month = nov,

day = "1",

language = "English",

volume = "30",

pages = "A209--A210",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Raz{\'o}n y Fe",

number = "11",

}

TY - JOUR

T1 - Regulatory and nonclinical considerations for translation of gene therapy medicinal products to first-in-human clinical trials

AU - Montané Mogas, Joel

N1 - J Montane,M Rayo, O Penon, N Coderch, C J Mann

PY - 2019/11/1

Y1 - 2019/11/1

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000495173100607?SID=EUW1ED0CEFzDdGcX0qHFJHlm23gT9

M3 - Meeting Abstract

SN - 1043-0342

VL - 30

SP - A209-A210

JO - Human Gene Therapy

JF - Human Gene Therapy

IS - 11

T2 - ESGCT 27th Annual Congress

Y2 - 1 January 2019

ER -